Article Archive
B&L's besifloxacin gets nod from FDA advisory
15 December 2008
Novel uses for old drugs target by new firm
15 December 2008
Pluristem gets $1.6M grant from Israel's OCS
15 December 2008
UK warning on Internet Rx drugs
15 December 2008
UCLA expert blames American values for health care crisis
15 December 2008
GSK donates to Carter Center to expand LF program
15 December 2008
FDA panel backs Allergan's Latisse
15 December 2008
FDA forges ties with WebMD for drug safety
15 December 2008
China IP enforcement issues; lessons from Merck & Co case
15 December 2008
Mass delays drug and device marketing law
15 December 2008
Stability testing of medicinal products
15 December 2008
Merck Serono extends Erbitux indication
15 December 2008
Takeda drops Cell's GVAX after deaths
15 December 2008
Bayer signs deal for ProStrakan's Tostrex
15 December 2008
NicOx signs supply deal with DSM
15 December 2008
FDA further delays Roche's Actemra over fears the drug may affect natal development and fertility
15 December 2008
Cuba invests $240M in pharma expansion
15 December 2008
Pfizer study bites back against claims generic CV drugs just as effective as branded
15 December 2008
Low vitamin K2 linked to hardening of arteries
15 December 2008
Generics favored over innovative drugs in central and eastern Europe
15 December 2008
Anticancer target of broccoli chemical found
15 December 2008
Folate in pregnancy linked to RTIs in infants
15 December 2008
Alkermes addiction drug enters Ph I testing
15 December 2008
Silence intends to submit CTA for anticancer RNAi
15 December 2008
Osiris starts Prochymal expanded access program in Canada
15 December 2008
Alkali-rich diet helps strengthen bones
15 December 2008
Faust changes name to Domain Therapeutics
15 December 2008
Astellas Pharma licenses Millipore's UCOE
15 December 2008
Destiny completes L4.8M financing round
15 December 2008
Anika fully enrolled for Monovisc OA study
15 December 2008
Epitherapeutics gets funding
15 December 2008
Forest gets unsolicited mini-tender offer
15 December 2008
Lipitor moves to preferred brand on CIGNA's Rx drug list
15 December 2008
Symphogen and Meiji advance Sym006 into preclinical testing
15 December 2008
US pharma DTC "recession" started in 2006
15 December 2008
Wyeth presents new Enbrel PA data
15 December 2008
Gilead publishes more Viread data in NEJM
15 December 2008
ConjuChem's Strong results for PC-DAC
15 December 2008
Novartis looks to single-pill BP drugs after study
15 December 2008
68% Swiss vote for heroin by Rx
15 December 2008
UK pediatric patient Rx compliance study
15 December 2008
Head of France's LEEM elected pres of health care federation
15 December 2008
Merck & Co's 2009 outlook below predictions due to forex effects and restructuring costs
15 December 2008
Sanofi-Aventis partners with Welvista to provide no-cost drugs
8 December 2008
Marshall Edwards files IND for triphendiol
8 December 2008
UK SFO loses appeal in price-fixing case
8 December 2008
Ono's interim results hit by NHI price cuts
8 December 2008
Santen's first-half income plummets 46%
8 December 2008
Beximco cleared to start exporting drugs Gulf
8 December 2008
Selenium supplements could slow AIDS
8 December 2008
US motavizumab appro delayed by info request
8 December 2008
Restructure swings GPC back into profit
8 December 2008
Panacos agrees to pay off Hercules loan
8 December 2008
Tamoxifen may worsen some breast cancers
8 December 2008
Actavis gets FDA appro for 150mg bupropion
8 December 2008
FDA delays Genta oncology drug
8 December 2008
Ferring is Auxilium's new EU partner for Testim
8 December 2008
Silence Thera reports strong early results for Atu027
8 December 2008
Generex' chewing gum bioequivalent to metformin
8 December 2008
J&J agrees to buy Mentor for $1.07B
8 December 2008
FDA grants OD status to antineoplastons for glioma
8 December 2008
US FDA swoops on YouTube "DTC abuse"
8 December 2008
Stock Commentary - Europe - week to Dec 1, 2008
8 December 2008
Stock Commentary - New York week to Dec 1, 2008
8 December 2008
US HIV/AIDS program hit target early
8 December 2008
US Part D rule "unclear;" Advantage plan options
8 December 2008
US physicians could end vaccinations
8 December 2008
J&J unit "tapped" for funds by pediatrician
8 December 2008
Neuropharm autism drug enters EMMA trial
8 December 2008
Enrollment complete in Ph III lubiprostone OIBD program
8 December 2008
Dosing begins in Ph Ib trial of Genaera's trodusquemine
8 December 2008
GSK reports strong results in asthma study
8 December 2008
Memory board investigated for fiduciary duty breach
8 December 2008
Biovail files ANDA for quetiapine
8 December 2008
Danish Biomonitor acquires Neutekbio
8 December 2008
Tigermed establishes subsidiary with CSU
8 December 2008
Newron secures 30M SwFr long-term standby equity line
8 December 2008
S*Bio initiates Ph I/II JAK2 inhibitor trial
8 December 2008
Bioheart files for European reimbursement for MyoCell
8 December 2008
DIA meeting in India postponed
8 December 2008
Catalyst Biosciences raises $40 million
8 December 2008
$1M Merck & Co research grant for NCCN
8 December 2008
Medicis and IMPAX settle over Solodyn, set up R&D accord
8 December 2008
France's warning on chronic diseases
8 December 2008
Challenges facing approval of combination products
8 December 2008
Farmindustria slams EC generic blocking claims
8 December 2008
AOK tender pressure for German generic firms
8 December 2008
Goldman's Symonds unveils early plans for R&D funding model focusing on specific areas
8 December 2008
Spectrum and Cell Therapeutics form JV for projected expansion in US sales of Zevalin
8 December 2008
Evotec enters 3-year deal with Novartis
8 December 2008
Intradigm awarded US patent for RNAi enhancement methods
8 December 2008
Anadys' HCV drug gets FDA fast-track status
8 December 2008
NPS initiates US Gattex trial in SBS
8 December 2008
Vical gets $1M-milestone from USA's Merck & Co
8 December 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
